Literature DB >> 2192194

Symptoms of hypoglycemia--a comparison between porcine and human insulin.

B Jakober1, T Lingenfelser, H Glück, T Maassen, D Overkamp, W Renn, M Eggstein.   

Abstract

For more than 2 years now it has been controversially debated whether awareness of hypoglycemia is reduced when type I diabetic patients are switched from porcine to human insulin. In order to address this question, we studied nine C-peptide negative diabetics (age 27.6 years, Broca index 106%, duration of diabetes 5.7 years, HbA1, 8.8%) in comparison with eight healthy volunteers (age 22.4 years, Broca index 104%). Following euglycemic monitoring overnight, a controlled hypoglycemia was induced by altering the algorithms of the Biostator. This was done in a double-blind, cross-over fashion using porcine or human insulin on 2 nonconsecutive days. There were no differences between the results obtained with respect to the time course of the study, blood glucose, amount of insulin infused, and concentration of venous free insulin achieved. Of the nine diabetics, eight were aware of hypoglycemia at a higher blood glucose level under porcine insulin. The first symptom of hypoglycemia was perceived at a mean blood glucose level of 61.1 +/- 5.4 mg/dl under porcine insulin and of 44.4 +/- 5.3 mg/dl under human insulin (P less than or equal to 0.05). Thirty symptoms were noted under porcine insulin exclusively or preferentially as opposed to only eight which were observed exclusively or preferentially under human insulin. The healthy volunteers evidenced fewer symptoms at lower blood glucose concentrations than the diabetics. The clear difference between human and porcine insulin could not unequivocally be reproduced in this group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192194     DOI: 10.1007/bf01648896

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system.

Authors:  O Szabo; A J Szabo
Journal:  Diabetes       Date:  1975-04       Impact factor: 9.461

2.  Warning symptoms of hypoglycaemia during treatment with human and porcine insulin in diabetes mellitus.

Authors:  W Berger; U Keller; B Honegger; E Jaeggi
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

3.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

4.  Hypoglycaemia unawareness in diabetics transferred from beef/porcine insulin to human insulin.

Authors:  A Teuscher; W G Berger
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man.

Authors:  C Rosak; P H Althoff; F Enzmann; K Schöffling
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

6.  Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.

Authors:  P J Boyle; N S Schwartz; S D Shah; W E Clutter; P E Cryer
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

7.  Role of brain in counterregulation of insulin-induced hypoglycemia in dogs.

Authors:  D W Biggers; S R Myers; D Neal; R Stinson; N B Cooper; J B Jaspan; P E Williams; A D Cherrington; R T Frizzell
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

  7 in total
  4 in total

1.  Hypoglycaemia with human and porcine insulins.

Authors:  M Egger; G D Smith; A Teuscher
Journal:  BMJ       Date:  1993-03-13

2.  Influence of human insulin on symptoms and awareness of hypoglycaemia: a randomised double blind crossover trial.

Authors:  M Egger; G D Smith; A U Teuscher; A Teuscher
Journal:  BMJ       Date:  1991-09-14

3.  Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms.

Authors:  G Kotzke; M Schütt; U Missler; D E Moller; H L Fehm; H H Klein
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

4.  Treatment of patients with human insulin.

Authors:  M R Kiln
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.